AIM ImmunoTech Inc. Revenue From Contract With Customer Excluding Assessed Tax

• AIM ImmunoTech Inc. showed a decrease of -48.2% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
• This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), AIM ImmunoTech Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 76.0%.
• Historical annual values: Fiscal year 2025: $88.0 thousand | Fiscal year 2024: $170.0 thousand | Fiscal year 2023: $202.0 thousand | Fiscal year 2022: $141.0 thousand | Fiscal year 2021: $135.0 thousand | Fiscal year 2020: $163.0 thousand | Fiscal year 2019: $140.0 thousand | Fiscal year 2018: $367.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026